These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38810324)

  • 21. [Relapse surveillance of patients with testicular germ cell tumor].
    Orillard E; Klajer E; Kalbacher E; Joly F; David A; Hervé L; Viot J; Mouillet G; Barkatz J; Kleinclauss F; Thiery-Vuillemin A
    Bull Cancer; 2019 Oct; 106(10):903-914. PubMed ID: 31495441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
    Cohn-Cedermark G; Stahl O; Tandstad T;
    Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.
    Chung P; O'Malley ME; Jewett MAS; Bedard PL; Panzarella T; Sturgeon J; Moore MJ; Hamilton R; Hansen AR; Anson-Cartwright L; Gospodarowicz M; Warde P
    Eur Urol Oncol; 2019 Jul; 2(4):437-442. PubMed ID: 31277780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
    Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
    J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.
    Detsky JS; Ghiam AF; Mamedov A; Commisso K; Commisso A; Zhang L; Liu S; Klotz L; Loblaw A; Vesprini D
    J Urol; 2020 Nov; 204(5):934-940. PubMed ID: 32330406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option.
    Hamilton RJ; Jewett MAS; Warde P; Hansen A
    Eur Urol Focus; 2019 Sep; 5(5):702-703. PubMed ID: 31129064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of surveillance for stage I testis cancer in the community.
    Yu HY; Madison RA; Setodji CM; Saigal CS
    J Clin Oncol; 2009 Sep; 27(26):4327-32. PubMed ID: 19652075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
    Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
    Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
    Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
    Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
    Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
    Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT restaging of testicular germ cell tumors: The incidence of isolated pelvic metastases.
    Sadow CA; Maurer AN; Prevedello LM; Sweeney CJ; Silverman SG
    Eur J Radiol; 2016 Aug; 85(8):1439-44. PubMed ID: 27423685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group.
    Rescorla FJ; Ross JH; Billmire DF; Dicken BJ; Villaluna D; Davis MM; Krailo M; Cullen JW; Olson TA; Egler RA; Amatruda JF; Rodrigues-Galindo C; Frazier AL
    J Pediatr Surg; 2015 Jun; 50(6):1000-3. PubMed ID: 25812445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
    Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
    JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.
    Pierorazio PM; Albers P; Black PC; Tandstad T; Heidenreich A; Nicolai N; Nichols C
    Eur Urol; 2018 Jun; 73(6):899-907. PubMed ID: 29338978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.